Columbus Regional Health is pleased to offer the OmniaSecure™ defibrillation lead, a novel advancement in transvenous ...

The simulation results presented here demonstrate the potential of the adaptive CRT device with dynamic optimization of AV and VV intervals for improving cardiac output beyond the current non-adaptive ...

The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy pacemakers after identifying a software- ...

Multiple societies covering cardiovascular medicine, electrophysiology, heart failure, and imaging have released updated appropriate use criteria (AUC) for various cardiac implantable electronic ...

DINAJPUR, April 30, 2026 (BSS) - For the first time in Dinajpur, a Cardiac Resynchronization Therapy (CRT) device has been ...

A novel bipolar conduction system pacing implantable cardioverter defibrillator lead demonstrated short-term safety and ...

Please provide your email address to receive an email when new articles are posted on . Major adverse events remained common in patients with nonischemic cardiomyopathy implanted with an electronic ...

Electrophysiologists at the Texas Cardiac Arrhythmia Institute at St. David’s Medical Center in Austin recently became the first in the U.S. to implant an FDA-approved leadless system for cardiac ...

Feasibility of portable stellate ganglion phototherapy device shown in retrospective analy ...

SAN DIEGO, CA—The observational BIO-LIBRA study, which enrolled nearly 50% women, has revealed important outcome differences by both sex and device type among patients with nonischemic cardiomyopathy ...